• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , Sept. 4

Zydus group, a global healthcare provider, announced the establishment of Zydus Pharma Inc that will market formulation generics and API in Japan.

The company will explore collaborations and alliances with Japanese pharmaceutical companies in areas like joint research and development, co-marketing, and contract manufacturing for API.

The firm includes generic drug firms and pharmaceutical venture companies. Mr Kazuhiro Kawabata, who has 30 years experience in the Japanese pharmaceutical industry and was the Director, Corporate Licensing and International Business Development of Eisai Co Ltd, will head the company headquartered in Shinjuku.

More Stories on : Overseas Investments | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Philips hives off Indian semiconductor biz to new entity

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line